5d 1m 3m 1y 5y 10y
There are no Focus articles on BPMUF.
There are no Transcripts on BPMUF.
There are no News articles on BPMUF.
BPMUF vs. ETF Alternatives
Tuesday, Jun 122012, 8:19 AM(GSK) is making another bolt-on acquisition to strengthen its lineup, agreeing to pay an initial £146M ($227M) to acquire eczema drug Toctino from Swiss biotech Basilea (BPMUF.PK). GSK will pay another £50M if Toctino passes its Phase III trial and receives FDA approval, and royalties on U.S. sales starting three years after launch. |Tuesday, Jun 122012, 8:19 AM| Comment!